These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 15855672

  • 21. [Estimation of "total" parathyroid hormone molecule (PTH-84)--diagnostic and therapeutic aspects].
    Kokot F.
    Pol Arch Med Wewn; 2002 Apr; 107(4):321-3. PubMed ID: 12189922
    [No Abstract] [Full Text] [Related]

  • 22. Sampling and storage conditions influencing the measurement of parathyroid hormone in blood samples: a systematic review.
    Hanon EA, Sturgeon CM, Lamb EJ.
    Clin Chem Lab Med; 2013 Oct; 51(10):1925-41. PubMed ID: 24072573
    [Abstract] [Full Text] [Related]

  • 23. Alfacalcidol therapy biphasically modifies the relationship between the plasma levels of intact PTH and osteocalcin in dialysis patients.
    Kazama JJ, Takamiya H.
    Nephron; 1998 Oct; 79(3):348-9. PubMed ID: 9678439
    [No Abstract] [Full Text] [Related]

  • 24. Evidence for a relationship between plasma immunoreactive calcitonin and bone disease in chronic renal failure.
    Kanis JA, Heynen G, Earnshaw M, Russell RG, Woods CG, Franchimont P, Gaspar S, Oliver D, Ledingham JG.
    Adv Exp Med Biol; 1977 Oct; 81():571-9. PubMed ID: 899941
    [No Abstract] [Full Text] [Related]

  • 25. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 26. Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients.
    Lee SA, Lee MJ, Ryu GW, Jhee JH, Kim HW, Park S, Jung SY, Oh HJ, Park JT, Han SH, Kang SW, Yoo TH.
    Osteoporos Int; 2016 Sep; 27(9):2717-2726. PubMed ID: 27216997
    [Abstract] [Full Text] [Related]

  • 27. [Effect of hemodialysis on serum N-PTH 1-34 and C-PTH 1-84 in renal failure (author's transl)].
    Uezu A, Ota K, Fujita T.
    Nihon Jinzo Gakkai Shi; 1979 Jan; 21(1):23-32. PubMed ID: 571930
    [No Abstract] [Full Text] [Related]

  • 28. Mysterious PTH values after parathyroidectomy in a patient on maintenance dialysis.
    Thompson M, Schiller B.
    Hemodial Int; 2009 Oct; 13(4):543-6. PubMed ID: 19732173
    [Abstract] [Full Text] [Related]

  • 29. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
    Lin YC, Lin YC, Hsu CY, Kao CC, Chang FC, Chen TW, Chen HH, Hsu CC, Wu MS, Taiwan Society of Nephrology.
    PLoS One; 2015 Oct; 10(6):e0129737. PubMed ID: 26107510
    [Abstract] [Full Text] [Related]

  • 30. Parathyroid hormone plasma level in untreated chronic renal failure and in hemodialyzed patients.
    Fuss M, De Backer M, Brauman J, Nijs-Dewolf N, Manderlier T, Brauman H, Corvilain J.
    Nephron; 1976 Oct; 17(2):144-54. PubMed ID: 940620
    [Abstract] [Full Text] [Related]

  • 31. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H, Baradaran A, Naderi AS.
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [Abstract] [Full Text] [Related]

  • 32. Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients.
    Marco MP, Martínez I, Amoedo ML, Borràs M, Saracho R, Almirall J, Fibla J, Fernández E.
    Kidney Int; 1999 Oct; 56(4):1349-53. PubMed ID: 10504487
    [Abstract] [Full Text] [Related]

  • 33. Stability of parathyroid hormone ex vivo in haemodialysis patients.
    Teal TK, Reed M, Stevens PE, Lamb EJ.
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):191-3. PubMed ID: 12662412
    [Abstract] [Full Text] [Related]

  • 34. Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.
    Melamed ML, Eustace JA, Plantinga LC, Jaar BG, Fink NE, Parekh RS, Coresh J, Yang Z, Cantor T, Powe NR.
    Nephrol Dial Transplant; 2008 May; 23(5):1650-8. PubMed ID: 18065788
    [Abstract] [Full Text] [Related]

  • 35. Targeting parathyroid hormone levels in dialysis patients.
    Saab G, Navaneethan SD, Slatopolsky E.
    Semin Dial; 2014 May; 27(6):562-5. PubMed ID: 25040125
    [No Abstract] [Full Text] [Related]

  • 36. Effects on serum parathyroid hormone of intravenous treatment with alphacalcidol in patients on chronic hemodialysis.
    Ljunghall S, Althoff P, Fellström B, Marjanovic B, Nisell J, Weiss L, Wide L.
    Nephron; 1990 May; 55(4):380-5. PubMed ID: 2392190
    [Abstract] [Full Text] [Related]

  • 37. Intact parathyroid hormone, ionized calcium and calcium infusion test in the evaluation of hyperparathyroidism in chronic renal failure.
    Pietilä K, Mörsky P, Pasternack A, Mustonen J, Koivula T.
    Nephron; 1987 May; 47(4):284-9. PubMed ID: 3696331
    [Abstract] [Full Text] [Related]

  • 38. Target levels for serum phosphorus and parathyroid hormone.
    Qunibi W, Kalantar-Zadeh K.
    Semin Dial; 2011 May; 24(1):29-33. PubMed ID: 21324001
    [No Abstract] [Full Text] [Related]

  • 39. Effect of haemodialysis on markers of bone turnover in children.
    Waller S, Ridout D, Rees L.
    Pediatr Nephrol; 2007 Apr; 22(4):586-92. PubMed ID: 17216258
    [Abstract] [Full Text] [Related]

  • 40. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H, Baradaran A.
    J Ayub Med Coll Abbottabad; 2004 Apr; 16(2):3-8. PubMed ID: 15455608
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.